|
|
Disclaimer:
This message is for the use of a Registered Medical Practitioner or a Hospital or a Laboratory only in Saudi Arabia. You are receiving this e-mail as we have your details as a healthcare professional. If you do not wish to receive these e-mails in future or unsubscribe, please click below. E-mail programs can consider these messages as junk mail and may automatically put them in your bulk or junk folder. To ensure the e-mails you've requested are delivered to your inbox, add our e-mail address to your address book. Please do not reply to this message. These e-mails are not monitored and do not accept replies.
For medical information, please contact GSK via [email protected]. To report adverse event/s associated with the use of GSK product/s, please contact us via [email protected]. To report the quality related product complaint/s associated with the use of GSK products, please contact us via [email protected].
About your privacy: GSK may monitor our technology tools and services (including e-mail, phone, and other communications sent to and from GSK) to maintain the security of systems, and to protect our staff, customers and business partners from cyber threats and loss of information. Examples of these monitoring activities include checks for offensive materials, viruses, and other malignant code, and unauthorized or unlawful activity. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws. You can learn about the information that we may process about you, and how we use your information, click here. You can also view our terms of use. Trademarks are owned by or licensed to the GSK group of companies.
Copyright © GlaxoSmithKline 2023. All rights reserved.
HCP data are collected for the purpose of SFDA disclosure and CME accreditation. By providing this information you are accepting the be low terms and condition of disclosure requirements
NX-SA-HZU-WCNT-240001 || Preparation date: April – 24
This message is for the use of a Registered Medical Practitioner or a Hospital or a Laboratory only in Saudi Arabia. You are receiving this e-mail as we have your details as a healthcare professional. If you do not wish to receive these e-mails in future or unsubscribe, please click below. E-mail programs can consider these messages as junk mail and may automatically put them in your bulk or junk folder. To ensure the e-mails you've requested are delivered to your inbox, add our e-mail address to your address book. Please do not reply to this message. These e-mails are not monitored and do not accept replies.
For medical information, please contact GSK via [email protected]. To report adverse event/s associated with the use of GSK product/s, please contact us via [email protected]. To report the quality related product complaint/s associated with the use of GSK products, please contact us via [email protected].
About your privacy: GSK may monitor our technology tools and services (including e-mail, phone, and other communications sent to and from GSK) to maintain the security of systems, and to protect our staff, customers and business partners from cyber threats and loss of information. Examples of these monitoring activities include checks for offensive materials, viruses, and other malignant code, and unauthorized or unlawful activity. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws. You can learn about the information that we may process about you, and how we use your information, click here. You can also view our terms of use. Trademarks are owned by or licensed to the GSK group of companies.
Copyright © GlaxoSmithKline 2023. All rights reserved.
HCP data are collected for the purpose of SFDA disclosure and CME accreditation. By providing this information you are accepting the be low terms and condition of disclosure requirements
NX-SA-HZU-WCNT-240001 || Preparation date: April – 24
